AstraZeneca Market Cap

AstraZeneca has a market cap or net worth of $240.81 billion as of August 14, 2025. Its market cap has decreased by -3.76% in one year.

Market Cap

240.81B

Enterprise Value

266.48B

Revenue

56.50B

Ranking

n/a

PE Ratio

29.03

Stock Price

$155.75

Market Cap Chart

Since May 28, 1993, AstraZeneca's market cap has increased from 7.10B to 240.81B, an increase of 3,291.21%. That is a compound annual growth rate of 11.55%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	240.81B	18.52%
Dec 31, 2024	203.17B	-2.91%
Dec 29, 2023	209.27B	-0.08%
Dec 30, 2022	209.44B	15.06%
Dec 31, 2021	182.03B	38.68%
Dec 31, 2020	131.26B	-0.69%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	798.20M
Tian'an Technology Group	628.15M
Glass House Brands	597.56M
Elite Pharmaceuticals	567.50M
Nika Pharmaceuticals	360.27M
Northwest Biotherapeutics	349.08M
American Oncology Network	337.45M
CytoDyn	325.38M

Market Cap Rankings